Literature DB >> 27252169

Distinct TLR-mediated cytokine production and immunoglobulin secretion in human newborn naïve B cells.

Matthew A Pettengill1, Simon D van Haren1, Ning Li2, David J Dowling3, Ilana Bergelson4, Jop Jans5, Gerben Ferwerda6, Ofer Levy7.   

Abstract

Neonatal innate immunity is distinct from that of adults, which may contribute to increased susceptibility to infection and limit vaccine responses. B cells play critical roles in protection from infection and detect PAMPs via TLRs, that, when co-activated with CD40, can drive B-cell proliferation and Ab production. We characterized the expression of TLRs in circulating B cells from newborns and adults, and evaluated TLR- and CD40-mediated naïve B-cell class-switch recombination (CSR) and cytokine production. Gene expression levels of most TLRs was similar between newborn and adult B cells, except that newborn naïve B cells expressed more TLR9 than adult naïve B cells. Neonatal naïve B cells demonstrated impaired TLR2- and TLR7- but enhanced TLR9-mediated cytokine production. Significantly fewer newborn naïve B cells underwent CSR to produce IgG, an impairment also noted with IL-21 stimulation. Additionally, co-stimulation via CD40 and TLRs induced greater cytokine production in adult B cells. Thus, while newborn naïve B cells demonstrate adult-level expression of TLRs and CD40, the responses to stimulation of these receptors are distinct. Relatively high expression of TLR9 and impaired CD40-mediated Ig secretion contributes to distinct innate and adaptive immunity of human newborns and may inform novel approaches to early-life immunization.
© The Author(s) 2016.

Entities:  

Keywords:  B lymphocyte; TLR; class-switch recombination; cytokine; neonatal

Mesh:

Substances:

Year:  2016        PMID: 27252169      PMCID: PMC4963298          DOI: 10.1177/1753425916651985

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  50 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

Authors:  Jennifer Huggins; Tina Pellegrin; Raymond E Felgar; Chungwen Wei; Miguel Brown; Bo Zheng; Eric C B Milner; Steven H Bernstein; Ignacio Sanz; Martin S Zand
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

3.  CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.

Authors:  Federica Capolunghi; Simona Cascioli; Ezio Giorda; Maria Manuela Rosado; Alessandro Plebani; Cinzia Auriti; Giulio Seganti; Roberta Zuntini; Simona Ferrari; Maria Cagliuso; Isabella Quinti; Rita Carsetti
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

4.  IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

Authors:  Rachel Ettinger; Gary P Sims; Anna-Marie Fairhurst; Rachel Robbins; Yong Sing da Silva; Rosanne Spolski; Warren J Leonard; Peter E Lipsky
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

5.  Expression of the costimulator molecules, CD40 and CD154, on lymphocytes from neonates and young children.

Authors:  S R Elliott; D M Roberton; H Zola; P J Macardle
Journal:  Hum Immunol       Date:  2000-04       Impact factor: 2.850

6.  Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells.

Authors:  R Krzysiek; E A Lefèvre; W Zou; A Foussat; J Bernard; A Portier; P Galanaud; Y Richard
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

Review 7.  Vaccine adjuvants: putting innate immunity to work.

Authors:  Robert L Coffman; Alan Sher; Robert A Seder
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

8.  CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells.

Authors:  Shweta Jain; Sathi Babu Chodisetti; Javed N Agrewala
Journal:  PLoS One       Date:  2011-06-02       Impact factor: 3.240

9.  Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn.

Authors:  D Brugnoni; P Airò; D Graf; M Marconi; M Lebowitz; A Plebani; S Giliani; F Malacarne; R Cattaneo; A G Ugazio
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

10.  Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells.

Authors:  R Endres; M B Alimzhanov; T Plitz; A Fütterer; M H Kosco-Vilbois; S A Nedospasov; K Rajewsky; K Pfeffer
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  16 in total

1.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

2.  An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates.

Authors:  Beth C Holbrook; S Tyler Aycock; Emily Machiele; Elene Clemens; Danielle Gries; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Immunology       Date:  2017-10-24       Impact factor: 7.397

3.  Activation of Innate Immune Responses by a CpG Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid.

Authors:  Margaret J Lange; Donald H Burke; John C Chaput
Journal:  Nucleic Acid Ther       Date:  2018-12-11       Impact factor: 5.486

4.  TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.

Authors:  David J Dowling; Simon D van Haren; Annette Scheid; Ilana Bergelson; Dhohyung Kim; Christy J Mancuso; Willemina Foppen; Al Ozonoff; Lynn Fresh; Terese B Theriot; Andrew A Lackner; Raina N Fichorova; Dmitri Smirnov; John P Vasilakos; Joe M Beaurline; Mark A Tomai; Cecily C Midkiff; Xavier Alvarez; James L Blanchard; Margaret H Gilbert; Pyone Pyone Aye; Ofer Levy
Journal:  JCI Insight       Date:  2017-03-23

5.  Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.

Authors:  David J Dowling; Soumik Barman; Alyson J Smith; Francesco Borriello; Danielle Chaney; Spencer E Brightman; Gandolina Melhem; Byron Brook; Manisha Menon; Dheeraj Soni; Simone Schüller; Karthik Siram; Etsuro Nanishi; Hélène G Bazin; David J Burkhart; Ofer Levy; Jay T Evans
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

Review 6.  The Impact of the Gut Microbiota on Humoral Immunity to Pathogens and Vaccination in Early Infancy.

Authors:  Quang N Nguyen; Jonathon E Himes; David R Martinez; Sallie R Permar
Journal:  PLoS Pathog       Date:  2016-12-22       Impact factor: 6.823

7.  Neonatal immune response to rhinovirus A16 has diminished dendritic cell function and increased B cell activation.

Authors:  Amanda Barlow-Anacker; Yury Bochkov; James Gern; Christine M Seroogy
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

8.  Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.

Authors:  Francesco Borriello; Carlo Pietrasanta; Jacqueline C Y Lai; Lois M Walsh; Pankaj Sharma; David N O'Driscoll; Juan Ramirez; Spencer Brightman; Lorenza Pugni; Fabio Mosca; David J Burkhart; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2017-12-12       Impact factor: 7.561

Review 9.  Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

Authors:  Ling Bai; Wei Chen; Jingtao Chen; Wei Li; Lei Zhou; Chao Niu; Wei Han; Jiuwei Cui
Journal:  J Transl Med       Date:  2017-02-27       Impact factor: 5.531

10.  Decreased production of class-switched antibodies in neonatal B cells is associated with increased expression of miR-181b.

Authors:  Stephanie Glaesener; Christine Jaenke; Anika Habener; Robert Geffers; Petra Hagendorff; Katrin Witzlau; Esther Imelmann; Andreas Krueger; Almut Meyer-Bahlburg
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.